This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- The Role of Functional Dopamine-Transporter SPECT Imaging in Parkinsonian Syndromes, Part 1
- Whole-Body Biodistribution and Radiation Dosimetry of 18F-FP-(+)-DTBZ (18F-AV-133): A Novel Vesicular Monoamine Transporter 2 Imaging Agent
- Progression from Unilateral to Bilateral Parkinsonism in Early Parkinson Disease: Implication of Mesocortical Dopamine Dysfunction by PET
- The scientific and clinical basis for the treatment of Parkinson disease (2009)
- Can we image premotor Parkinson disease?
- Optimized, Automated Striatal Uptake Analysis Applied to SPECT Brain Scans of Parkinson's Disease Patients
- Pharmacological Characterization of (E)-N-(4-Fluorobut-2-enyl)-2beta-carbomethoxy-3beta-(4'-tolyl)nortropane (LBT-999) as a Highly Promising Fluorinated Ligand for the Dopamine Transporter
- Absolute Quantification in Dopaminergic Neurotransmission SPECT Using a Monte Carlo-Based Scatter Correction and Fully 3-Dimensional Reconstruction
- [99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease
- Striatal Dopamine Transporter Imaging Correlates with Anxiety and Depression Symptoms in Parkinson's Disease
- Sensitivity and Specificity of 99mTc-TRODAT-1 SPECT Imaging in Differentiating Patients with Idiopathic Parkinson's Disease from Healthy Subjects
- Reproducibility of 99mTc-TRODAT-1 SPECT Measurement of Dopamine Transporters in Parkinson's Disease
- Crossover Study of 99mTc-TRODAT-1 SPECT and 18F-FDOPA PET in Parkinson's Disease Patients
- Dopamine Transporter Concentration Is Reduced in Asymptomatic Machado-Joseph Disease Gene Carriers
- Evaluation of Early-Stage Parkinson's Disease with 99mTc-TRODAT-1 Imaging